Two proposed rules released Monday would pare back government guardrails around health information technology software, including some put forward by the Biden administration.

The Food and Drug Administration on Monday approved an oral version of Novo Nordisk’s weight loss medication Wegovy, setting ...

On Friday, the healthcare behemoth released results of three highly anticipated external reviews that drilled down on a ...

The Trump administration has largely taken a deregulatory stance on artificial intelligence in a bid to avoid hampering the technology’s rollout ...

The proposed rule aims to tamp down on unwieldy price data files and change how some prices are reported.

On Friday, President Trump announced agreements with nine more drugmakers that he said would significantly lower the prices ...

The providers said they can best serve their communities by operating independently. The deal would have created a health ...

The value-based care pilot will be replaced by ACO LEAD, a new model that providers and analysts say seems to address many of the problems posed by its predecessor.

Under new proposed rules, hospitals would lose federal funding if they offer treatments including puberty blockers, hormone ...

PBMs are pivoting reimbursement models to protect pharmacies from what they say is an unsustainable status quo.

The legislation makes no mention of the financial assistance, setting the subsidies up to lapse in just a few weeks.

Dealmaking in the sector is poised to increase next year after a lull in 2025, as companies use technology, like artificial intelligence, to attract buyers, according to the report.